{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:23:03Z","timestamp":1794565383173,"version":"4.9.1"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82200390"],"award-info":[{"award-number":["82200390"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.diabres.2026.113336","type":"journal-article","created":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T13:52:24Z","timestamp":1779630744000},"page":"113336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Risk stratification in early-stage Cardiovascular-Kidney-Metabolic Syndrome: The Potency of visceral adiposity and insulin resistance surrogate indices"],"prefix":"10.1016","volume":"237","author":[{"given":"Lingyan","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufeng","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2026.113336_b0005","article-title":"Large-scale plasma proteomics for predicting future cardiovascular and all-cause mortality among individuals with cardiovascular-kidney-metabolic syndrome stage 0-3","volume":"179","author":"Weng","year":"2026","journal-title":"Metabolism[J]"},{"issue":"17","key":"10.1016\/j.diabres.2026.113336_b0010","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1161\/CIRCULATIONAHA.125.077894","article-title":"Cardiovascular-kidney-metabolic syndrome stages, echocardiographic characteristics, and heart failure risk: the atherosclerosis risk in communities study","volume":"153","author":"Lassen","year":"2026","journal-title":"Circulation[J]"},{"issue":"20","key":"10.1016\/j.diabres.2026.113336_b0015","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American heart association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation[J]"},{"issue":"20","key":"10.1016\/j.diabres.2026.113336_b0020","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A Synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American heart association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation[J]"},{"key":"10.1016\/j.diabres.2026.113336_b0025","doi-asserted-by":"crossref","unstructured":"Aggarwal R, Ostrominski JW, Vaduganathan M. Prevalence of Cardiovascular-Kidney-Metabolic Syndrome Stages in US Adults, 2011-2020. Jama[J], 2024, 331(21): 1858-1860.","DOI":"10.1001\/jama.2024.6892"},{"key":"10.1016\/j.diabres.2026.113336_b0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41574-026-01239-8","article-title":"Clinical obesity in asian people: bridging the gap between adiposity and disease","author":"Lim","year":"2026","journal-title":"Nat Rev Endocrinol[J]"},{"issue":"20","key":"10.1016\/j.diabres.2026.113336_b0035","article-title":"Complementary role of BMI and EOSS in predicting all-cause and cause-specific mortality in people with overweight and obesity","volume":"16","author":"Bioletto","year":"2024","journal-title":"Nutrients[J]"},{"issue":"2","key":"10.1016\/j.diabres.2026.113336_b0040","article-title":"Gaps in current cardiometabolic risk assessment: a review supporting the development of the C.O.R.E. indicator model","volume":"15","author":"Geraci","year":"2026","journal-title":"J Clin Med[J]"},{"issue":"1","key":"10.1016\/j.diabres.2026.113336_b0045","first-page":"1","article-title":"Contribution of adipose tissue inflammation to the development of type 2 diabetes mellitus","volume":"9","author":"Burhans","year":"2018","journal-title":"Compr Physiol[J]"},{"issue":"23","key":"10.1016\/j.diabres.2026.113336_b0050","article-title":"Beyond BMI: rethinking obesity metrics and cardiovascular risk in the era of precision medicine","volume":"15","author":"Tanasescu","year":"2025","journal-title":"Diagnostics (Basel)[J]"},{"key":"10.1016\/j.diabres.2026.113336_b0055","article-title":"The pathophysiology of visceral adipose tissues in cardiometabolic diseases","volume":"222","author":"Lee","year":"2024","journal-title":"Biochem Pharmacol[J]"},{"issue":"9","key":"10.1016\/j.diabres.2026.113336_b0060","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1161\/ATVBAHA.114.303035","article-title":"Links between ectopic fat and vascular disease in humans","volume":"34","author":"Lim","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol[J]"},{"issue":"12","key":"10.1016\/j.diabres.2026.113336_b0065","article-title":"From adipose to ailing kidneys: the role of lipid metabolism in obesity-related chronic kidney disease","volume":"13","author":"Xu","year":"2024","journal-title":"Antioxidants (Basel)[J]"},{"issue":"9","key":"10.1016\/j.diabres.2026.113336_b0070","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","article-title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement","volume":"7","author":"Neeland","year":"2019","journal-title":"Lancet Diabetes Endocrinol[J]"},{"issue":"5","key":"10.1016\/j.diabres.2026.113336_b0075","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/j.clnu.2019.07.012","article-title":"Metabolic score for Visceral Fat (METS-VF), a novel estimator of intra-abdominal fat content and cardio-metabolic health","volume":"39","author":"Bello-Chavolla","year":"2020","journal-title":"Clin Nutr[J]"},{"issue":"4","key":"10.1016\/j.diabres.2026.113336_b0080","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2337\/dc09-1825","article-title":"Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk","volume":"33","author":"Amato","year":"2010","journal-title":"Diabetes Care[J]"},{"key":"10.1016\/j.diabres.2026.113336_b0085","doi-asserted-by":"crossref","first-page":"38214","DOI":"10.1038\/srep38214","article-title":"A indicator of visceral adipose dysfunction to evaluate metabolic health in adult chinese","volume":"6","author":"Xia","year":"2016","journal-title":"Sci Rep[J]"},{"key":"10.1016\/j.diabres.2026.113336_b0090","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2261-5-26","article-title":"The \u201clipid accumulation product\u201d performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison","volume":"5","author":"Kahn","year":"2005","journal-title":"BMC Cardiovasc Disord[J]"},{"issue":"4","key":"10.1016\/j.diabres.2026.113336_b0095","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/met.2008.0034","article-title":"The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects","volume":"6","author":"Simental-Mend\u00eda","year":"2008","journal-title":"Metab Syndr Relat Disord[J]"},{"issue":"5","key":"10.1016\/j.diabres.2026.113336_b0100","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/EJE-17-0883","article-title":"METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes","volume":"178","author":"Bello-Chavolla","year":"2018","journal-title":"Eur J Endocrinol[J]"},{"issue":"11","key":"10.1016\/j.diabres.2026.113336_b0105","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1002\/oby.20408","article-title":"Relationships between body roundness with body fat and visceral adipose tissue emerging from a new geometrical model","volume":"21","author":"Thomas","year":"2013","journal-title":"Obesity (Silver Spring)[J]"},{"key":"10.1016\/j.diabres.2026.113336_b0110","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.2147\/DMSO.S266277","article-title":"Metabolic score for visceral Fat (METS-VF) estimation - a novel cost-effective obesity indicator for visceral adipose tissue estimation","volume":"13","author":"Kapoor","year":"2020","journal-title":"Diabetes Metab Syndr Obes[J]"},{"key":"10.1016\/j.diabres.2026.113336_b0115","article-title":"Metabolic score for Visceral Fat: a reliable indicator of visceral obesity for predicting risk for hypertension","volume":"93","author":"Feng","year":"2022","journal-title":"Nutrition[J]"},{"issue":"1","key":"10.1016\/j.diabres.2026.113336_b0120","article-title":"Visceral fat metabolism score and cardiovascular-kidney-metabolic syndrome stages in all-cause and cause-specific mortality: insights from UK Biobank","volume":"23","author":"Bai","year":"2026","journal-title":"Nutr Metab (Lond)[J]"},{"key":"10.1016\/j.diabres.2026.113336_b0125","article-title":"Cardiovascular-kidney-metabolic syndrome stages and increased risk of all-cause and cause-specific mortality in UK Biobank","volume":"25","author":"Xu","year":"2026","journal-title":"Am J Prev Cardiol[J]"},{"issue":"12","key":"10.1016\/j.diabres.2026.113336_b0130","doi-asserted-by":"crossref","first-page":"5870","DOI":"10.1111\/dom.15959","article-title":"Association of metabolic score for visceral fat with all-cause mortality, cardiovascular mortality, and cancer mortality: a prospective cohort study","volume":"26","author":"Jia","year":"2024","journal-title":"Diabetes Obes Metab[J]"},{"key":"10.1016\/j.diabres.2026.113336_b0135","article-title":"Associations between metabolic score for visceral fat and the risk of cardiovascular disease and all-cause mortality among populations with different glucose tolerance statuses","volume":"203","author":"Zhu","year":"2023","journal-title":"Diabetes Res Clin Pract[J]"},{"issue":"1","key":"10.1016\/j.diabres.2026.113336_b0140","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12933-025-02735-3","article-title":"Life's Essential 8 cardiovascular health, cardiovascular-kidney-metabolic syndrome stages, and incident cardiovascular events: a nationwide 10-year prospective cohort study in China","volume":"24","author":"Li","year":"2025","journal-title":"Cardiovasc Diabetol[J]"},{"key":"10.1016\/j.diabres.2026.113336_b0145","article-title":"Non-linear associations and threshold effects of oxidative balance score and composite dietary antioxidant index on frailty risk in patients with cardiovascular-kidney-metabolic syndrome","volume":"12","author":"Wang","year":"2025","journal-title":"Front Nutr[J]"},{"issue":"1","key":"10.1016\/j.diabres.2026.113336_b0150","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12872-026-05511-7","article-title":"Metabolic score for visceral fat profiles and incident cardiovascular disease in adults with CKM syndrome stages 0-3: a CHARLS longitudinal study","volume":"26","author":"Zhang","year":"2026","journal-title":"BMC Cardiovasc Disord[J]"},{"issue":"1","key":"10.1016\/j.diabres.2026.113336_b0155","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1152\/ajpcell.00499.2025","article-title":"Cardiovascular-kidney-metabolic syndrome: prevalence, risks, disease trajectories, and early-stage management","volume":"330","author":"Gunnarsson","year":"2026","journal-title":"Am J Physiol Cell Physiol[J]"},{"key":"10.1016\/j.diabres.2026.113336_b0160","article-title":"Association between cumulative metabolic score for visceral fat and cardiovascular disease risk in cardiovascular-kidney-metabolic syndrome stage 0-3 patients: a prospective cohort analysis based on CHARLS database","author":"Chen","year":"2026","journal-title":"BMC Cardiovasc Disord[J]"},{"key":"10.1016\/j.diabres.2026.113336_b0165","article-title":"Association between triglyceride-glucose index and related indicators with heart failure-related mortality in individuals with early-stage cardiovascular-kidney-metabolic syndrome","author":"Jin","year":"2026","journal-title":"Cardiovasc Diabetol[J]"},{"issue":"12","key":"10.1016\/j.diabres.2026.113336_b0170","article-title":"Prevalence of Cardiovascular-Kidney-Metabolic (CKM) Syndrome in Lithuanian adults: insights from a Nationwide Real-World Study using Electronic Health Records","volume":"61","author":"Urbonas","year":"2025","journal-title":"Medicina (Kaunas)[J]"},{"issue":"1","key":"10.1016\/j.diabres.2026.113336_b0175","article-title":"Triglyceride-glucose index and mortality in critically ill patients with cardiovascular-kidney-metabolic syndrome stage 4","volume":"25","author":"Yin","year":"2026","journal-title":"Cardiovasc Diabetol[J]"},{"issue":"3","key":"10.1016\/j.diabres.2026.113336_b0180","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000471488","article-title":"The metabolic phenotype in obesity: fat mass, body fat distribution, and adipose tissue function","volume":"10","author":"Goossens","year":"2017","journal-title":"Obes Facts[J]"},{"issue":"21","key":"10.1016\/j.diabres.2026.113336_b0185","first-page":"e984","article-title":"Obesity and cardiovascular disease: a scientific statement from the American heart association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation[J]"},{"issue":"2","key":"10.1016\/j.diabres.2026.113336_b0190","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cmet.2017.07.008","article-title":"Characteristics, and consequences of metabolically unhealthy normal weight in humans","volume":"26","author":"Stefan","year":"2017","journal-title":"Cell Metab[J]"},{"issue":"1","key":"10.1016\/j.diabres.2026.113336_b0195","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.metabol.2015.10.019","article-title":"Metabolic health and weight: understanding metabolically unhealthy normal weight or metabolically healthy obese patients","volume":"65","author":"Mathew","year":"2016","journal-title":"Metabolism[J]"},{"issue":"3","key":"10.1016\/j.diabres.2026.113336_b0200","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/1941738111404655","article-title":"Body mass index and percentage of body fat as indicators for obesity in an adolescent athletic population","volume":"3","author":"Etchison","year":"2011","journal-title":"Sports Health[J]"},{"issue":"9403","key":"10.1016\/j.diabres.2026.113336_b0205","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","volume":"363","year":"2004","journal-title":"Lancet[J]"},{"issue":"12","key":"10.1016\/j.diabres.2026.113336_b0210","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMra1011035","article-title":"Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease","volume":"371","author":"Shulman","year":"2014","journal-title":"N Engl J Med[J]"},{"issue":"3","key":"10.1016\/j.diabres.2026.113336_b0215","article-title":"CD36 and its role in obesity","volume":"27","author":"Garcia","year":"2026","journal-title":"Obes Rev[J]"},{"key":"10.1016\/j.diabres.2026.113336_b0220","doi-asserted-by":"crossref","unstructured":"Fang Z, Yuan J, Qiu J, et al. Association between visceral lipid accumulation indicators and advanced cardiovascular-kidney-metabolic syndrome: a cross-sectional study based on NHANES 1999-2018. Cardiorenal Med[J], 2025, 15(1): 1-30.","DOI":"10.1159\/000547533"},{"issue":"1","key":"10.1016\/j.diabres.2026.113336_b0225","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12933-025-02842-1","article-title":"Triglyceride-glucose-related indices and risk of cardiovascular disease and mortality in individuals with cardiovascular-kidney-metabolic (CKM) syndrome stages 0-3: a prospective cohort study of 282,920 participants in the UK Biobank","volume":"24","author":"Liu","year":"2025","journal-title":"Cardiovasc Diabetol[J]"},{"issue":"3","key":"10.1016\/j.diabres.2026.113336_b0230","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1467-789X.2011.00952.x","article-title":"Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis","volume":"13","author":"Ashwell","year":"2012","journal-title":"Obes Rev[J]"},{"issue":"6","key":"10.1016\/j.diabres.2026.113336_b0235","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/ajcn\/nqy208","article-title":"Alterations in branched-chain amino acid kinetics in nonobese but insulin-resistant asian men","volume":"108","author":"Tan","year":"2018","journal-title":"Am J Clin Nutr[J]"},{"issue":"1","key":"10.1016\/j.diabres.2026.113336_b0240","doi-asserted-by":"crossref","first-page":"16753","DOI":"10.1038\/s41598-018-35073-4","article-title":"A novel adiposity index as an integrated predictor of cardiometabolic disease morbidity and mortality","volume":"8","author":"Park","year":"2018","journal-title":"Sci Rep[J]"},{"issue":"1","key":"10.1016\/j.diabres.2026.113336_b0245","article-title":"Association of various insulin resistance surrogate indices with aging acceleration and future risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: insights from CHARLS 2011-2020 data","volume":"25","author":"Han","year":"2026","journal-title":"Cardiovasc Diabetol[J]"},{"key":"10.1016\/j.diabres.2026.113336_b0250","doi-asserted-by":"crossref","unstructured":"Tripathi H, Singh A, Farheen, et al. The Metabolic Score for Visceral Fat (METS-VF) as a predictor of diabetes mellitus: Evidence from the 2011-2018 NHANES study. PLoS One[J], 2025, 20(2): e0317913.","DOI":"10.1371\/journal.pone.0317913"},{"issue":"1","key":"10.1016\/j.diabres.2026.113336_b0255","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s13098-025-02016-9","article-title":"Metabolic score for visceral fat as a superior predictor of frailty in overweight and obese adults: a cross-sectional NHANES analysis (2007-2020)","volume":"17","author":"Zhan","year":"2025","journal-title":"Diabetol Metab Syndr[J]"},{"issue":"7","key":"10.1016\/j.diabres.2026.113336_b0260","article-title":"Visceral fat reference values derived from healthy European men and women aged 20-30 years using GE Healthcare dual-energy x-ray absorptiometry","volume":"12","author":"Miazgowski","year":"2017","journal-title":"PLoS One[J]"},{"issue":"1","key":"10.1016\/j.diabres.2026.113336_b0265","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12933-021-01268-9","article-title":"Triglyceride-glucose index and the incidence of atherosclerotic cardiovascular diseases: a meta-analysis of cohort studies","volume":"20","author":"Ding","year":"2021","journal-title":"Cardiovasc Diabetol[J]"},{"key":"10.1016\/j.diabres.2026.113336_b0270","article-title":"Association of the metabolic score for insulin resistance with cardiovascular diseases, cardiovascular and all-cause mortality in chinese hypertensive population","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Endocrinol (Lausanne)[J]"},{"issue":"1","key":"10.1016\/j.diabres.2026.113336_b0275","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12876-025-03833-y","article-title":"Metabolic score for visceral fat is correlated with all-cause and cardiovascular mortality among individuals with non-alcoholic fatty liver disease","volume":"25","author":"Xie","year":"2025","journal-title":"BMC Gastroenterol[J]"},{"issue":"24","key":"10.1016\/j.diabres.2026.113336_b0280","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","article-title":"Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American heart association","volume":"148","author":"Khan","year":"2023","journal-title":"Circulation[J]"},{"issue":"6","key":"10.1016\/j.diabres.2026.113336_b0285","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and validation of the American heart association's PREVENT equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation[J]"},{"key":"10.1016\/j.diabres.2026.113336_b0290","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2147\/CLEP.S395938","article-title":"The Metabolic score for insulin resistance (METS-IR) predicts cardiovascular disease and its subtypes in patients with hypertension and obstructive sleep Apnea","volume":"15","author":"Yang","year":"2023","journal-title":"Clin Epidemiol[J]"},{"key":"10.1016\/j.diabres.2026.113336_b0295","article-title":"Mets-IR as a predictor of cardiovascular events in the middle-aged and elderly population and mediator role of blood lipids","volume":"14","author":"Qian","year":"2023","journal-title":"Front Endocrinol (Lausanne)[J]"},{"issue":"1","key":"10.1016\/j.diabres.2026.113336_b0300","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1186\/s12889-024-19186-2","article-title":"Association between metabolic score of visceral fat and carotid atherosclerosis in chinese health screening population: a cross-sectional study","volume":"24","author":"Qian","year":"2024","journal-title":"BMC Public Health[J]"},{"issue":"1","key":"10.1016\/j.diabres.2026.113336_b0305","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12933-022-01456-1","article-title":"Cumulative triglyceride-glucose index is a risk for CVD: a prospective cohort study","volume":"21","author":"Cui","year":"2022","journal-title":"Cardiovasc Diabetol[J]"},{"issue":"18","key":"10.1016\/j.diabres.2026.113336_b0310","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1161\/CIR.0b013e318233bc6a","article-title":"Assessing adiposity: a scientific statement from the American heart association","volume":"124","author":"Cornier","year":"2011","journal-title":"Circulation[J]"},{"key":"10.1016\/j.diabres.2026.113336_b0315","doi-asserted-by":"crossref","DOI":"10.1038\/s41366-026-02079-2","article-title":"Racial and ethnic disparities in type 2 diabetes: does visceral fat play a role? evidence from the MESA study","author":"Xia","year":"2026","journal-title":"Int J Obes (Lond)[J]"},{"issue":"2","key":"10.1016\/j.diabres.2026.113336_b0320","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1152\/physrev.00011.2023","article-title":"CD36 as a gatekeeper of myocardial lipid metabolism and therapeutic target for metabolic disease","volume":"104","author":"Glatz","year":"2024","journal-title":"Physiol Rev[J]"},{"issue":"12","key":"10.1016\/j.diabres.2026.113336_b0325","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrneph.2017.126","article-title":"CD36 in chronic kidney disease: novel insights and therapeutic opportunities","volume":"13","author":"Yang","year":"2017","journal-title":"Nat Rev Nephrol[J]"},{"issue":"18","key":"10.1016\/j.diabres.2026.113336_b0330","article-title":"Impaired fatty acid metabolism perpetuates lipotoxicity along the transition to chronic kidney injury","volume":"7","author":"Rinaldi","year":"2022","journal-title":"JCI Insight[J]"},{"key":"10.1016\/j.diabres.2026.113336_b0335","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ebiom.2019.10.023","article-title":"Uncoupling protein 1 inhibits mitochondrial reactive oxygen species generation and alleviates acute kidney injury","volume":"49","author":"Jia","year":"2019","journal-title":"EBioMedicine[J]"},{"issue":"6","key":"10.1016\/j.diabres.2026.113336_b0340","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.tcb.2020.02.009","article-title":"Emerging mechanisms and disease relevance of ferroptosis","volume":"30","author":"Stockwell","year":"2020","journal-title":"Trends Cell Biol[J]"},{"issue":"10","key":"10.1016\/j.diabres.2026.113336_b0345","doi-asserted-by":"crossref","first-page":"45117","DOI":"10.31083\/RCM45117","article-title":"Ferroptosis of macrophages and endothelial cells in atherosclerosis: molecular mechanisms and therapeutic targets","volume":"26","author":"Jiang","year":"2025","journal-title":"Rev Cardiovasc Med[J]"},{"issue":"3","key":"10.1016\/j.diabres.2026.113336_b0350","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41574-019-0310-7","article-title":"Waist circumference as a vital sign in clinical practice: a consensus statement from the IAS and ICCR working group on visceral obesity","volume":"16","author":"Ross","year":"2020","journal-title":"Nat Rev Endocrinol[J]"},{"issue":"7","key":"10.1016\/j.diabres.2026.113336_b0355","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S2213-8587(20)30110-8","article-title":"Causes, consequences, and treatment of metabolically unhealthy fat distribution","volume":"8","author":"Stefan","year":"2020","journal-title":"Lancet Diabetes Endocrinol[J]"},{"issue":"25_suppl_2","key":"10.1016\/j.diabres.2026.113336_b0360","first-page":"S49","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation[J]"},{"issue":"1","key":"10.1016\/j.diabres.2026.113336_b0365","article-title":"The association between modified cardiometabolic index and cardiovascular disease risk in adults with early cardiovascular-kidney-metabolic syndrome: a prospective cohort study","volume":"26","author":"Wang","year":"2026","journal-title":"BMC Cardiovasc Disord[J]"},{"issue":"5","key":"10.1016\/j.diabres.2026.113336_b0370","article-title":"Biomarkers for screening and diagnosis of heart failure in cardiovascular-kidney-metabolic syndrome a narrative review","volume":"27","author":"Pintea","year":"2026","journal-title":"Int J Mol Sci[J]"},{"issue":"20","key":"10.1016\/j.diabres.2026.113336_b0375","first-page":"2129","article-title":"Diabetes in Asia: epidemiology, risk factors, and pathophysiology","volume":"301","author":"Chan","year":"2009","journal-title":"Jama[J]"},{"issue":"2","key":"10.1016\/j.diabres.2026.113336_b0380","article-title":"Metabolic dysfunction-associated steatotic liver disease and type 2 diabetes: pathophysiology, diagnosis, and emerging therapeutic strategies","volume":"17","author":"Suresh","year":"2026","journal-title":"World J Diabetes[J]"},{"issue":"1","key":"10.1016\/j.diabres.2026.113336_b0385","article-title":"Interplay of childhood metabolic dysfunction-associated steatotic liver disease and obesity in the development of youth-onset type 2 diabetes","volume":"15","author":"Parizad","year":"2026","journal-title":"World J Clin Pediatr[J]"},{"issue":"9","key":"10.1016\/j.diabres.2026.113336_b0390","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1038\/s41591-022-01981-2","article-title":"Multimodal biomedical AI","volume":"28","author":"Acosta","year":"2022","journal-title":"Nat Med[J]"},{"key":"10.1016\/j.diabres.2026.113336_b0395","article-title":"Artificial intelligence for cardiovascular risk prediction: an umbrella review of applications and translational challenges","volume":"22","author":"Parizad","year":"2026","journal-title":"Vasc Health Risk Manag[J]"},{"issue":"1","key":"10.1016\/j.diabres.2026.113336_b0400","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s10916-024-02087-7","article-title":"A systematic review of artificial intelligence models for time-to-event outcome applied in cardiovascular disease risk prediction","volume":"48","author":"Teshale","year":"2024","journal-title":"J Med Syst[J]"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726002561?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726002561?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:22:41Z","timestamp":1794561761000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726002561"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":80,"alternative-id":["S0168822726002561"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113336","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk stratification in early-stage Cardiovascular-Kidney-Metabolic Syndrome: The Potency of visceral adiposity and insulin resistance surrogate indices","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113336","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"113336"}}